Christina M. Ackermann
2020
In 2020, Christina M. Ackermann earned a total compensation of $3.5M as Executive Vice President, General Counsel and Head of Commercial Operations at Valeant Pharmaceuticals International, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $540,000 |
|---|---|
| Option Awards | $540,362 |
| Salary | $743,654 |
| Stock Awards | $1,692,387 |
| Other | $24,625 |
| Total | $3,541,028 |
Ackermann received $1.7M in stock awards, accounting for 48% of the total pay in 2020.
Ackermann also received $540K in non-equity incentive plan, $540.4K in option awards, $743.7K in salary and $24.6K in other compensation.
Rankings
In 2020, Christina M. Ackermann's compensation ranked 3,271st out of 13,090 executives tracked by ExecPay. In other words, Ackermann earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,271 out of 13,090 | 75th |
Division Manufacturing | 1,269 out of 5,617 | 77th |
Major group Chemicals And Allied Products | 479 out of 2,248 | 79th |
Industry group Drugs | 415 out of 1,948 | 79th |
Industry Pharmaceutical Preparations | 309 out of 1,453 | 79th |
Source: SEC filing on May 2, 2022.
Ackermann's colleagues
We found four more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2020.
2020
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2020
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2020
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
2020
Sam Eldessouky
Valeant Pharmaceuticals International